By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Dana-Farber Cancer Institute 

44 Binney Street

Boston  Massachusetts  02115  U.S.A.
Phone: 617-632-3000 Fax: n/a

The mission of Dana-Farber Cancer Institute is to provide expert, compassionate care to children and adults with cancer while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases. As an affiliate of Harvard Medical School and a Comprehensive Cancer Center designated by the National Cancer Institute, the Institute also provides training for new generations of physicians and scientists, designs programs that promote public health particularly among high-risk and underserved populations, and disseminates innovative patient therapies and scientific discoveries to our target community across the United States and throughout the world.


Dana-Farber Cancer Institute's ultimate goal is the eradication of cancer, AIDS, and related diseases and the fear that they engender.

Core Values


Above all else, we make a difference by relieving the burden of disease now and for the future through our research, clinical care, education, outreach and advocacy.

We pursue excellence relentlessly and with integrity in all that we do, adhering always to the highest standards of conduct.

Compassion and Respect
For those in our care and for one another.

We foster the spirit of inquiry, promoting collaboration and innovation across traditional boundaries while celebrating individual creativity.

Key Statistics

Ownership: Private

Web Site: Dana-Farber Cancer Institute

Company News
Initial Results From Dana-Farber Cancer Institute Personalized Neoantigen Vaccine Published In Nature 7/6/2017 7:21:24 AM
Atreca And Dana-Farber Cancer Institute Establish Broad Cancer Immunotherapy R&D Collaboration 5/31/2017 12:07:37 PM
Actinium (ATNM.OB) Announces Appointment Of Hematology Expert Dr. Richard Stone Of The Dana-Farber Cancer Institute To Its Scientific Advisory Board 5/17/2017 11:04:53 AM
Cannabis Science And Dana-Farber Cancer Institute /Harvard Cancer Center (DF/HCC) Announce Joint Research And Drug Development Agreement; Collaborative Research Agreement 1/9/2017 1:12:52 PM
'Retired' Former Novartis AG (NVS) R&D Cancer Head Returns for a New Gig at the Dana-Farber Cancer Institute 11/23/2016 5:43:14 AM
Xenetic Biosciences Appoints Edward J. Benz, Jr., M.D., Former Dana-Farber Cancer Institute CEO, To Its Board Of Directors 11/22/2016 10:38:29 AM
Daiichi Sankyo And Dana-Farber Cancer Institute Announce Lung Cancer Research Collaboration 10/12/2016 7:24:39 AM
Nestlé Health Science Supports Dana-Farber Cancer Institute On Study Investigating The Impact Of Weight Loss On Breast Cancer Recurrence 10/11/2016 10:58:39 AM
How Trump Was Named "Grand Benefactor" For A Dana-Farber Cancer Institute Gala Without Donating A Penny 9/29/2016 7:07:41 AM
Senior Director Of Dana-Farber Cancer Institute, Office For Human Research Studies Joins Schulman IRB As VP For Oncology Services 7/12/2016 8:27:19 AM